BisphosphonatesHeidi Powell, MD Literature reviewed August 06, 2006. Updated June 22, 2009
Click an answer under each question.
You tell her she meets criteria for "low bone mass" or "osteopenia" (T-score -1 to -2.5) but that does not mean that she has osteoporosis. For osteopenic postmenopausal women like your patient, which of the following statements is true regarding alendronate or other bisphosphonates?
What additional study might help you determine whether treatment is indicated in this woman?
A lateral spine film shows the following:
She has a vertebral fracture and would benefit from treatment of osteoporosis. You counsel your patient regarding adequate calcium and vitamin D. Which of the following regimens do you recommend to her?
What can you tell her about fracture risk reduction with alendronate in osteoporotic postmenopausal women?
She wants to know what side effects she might experience with alendronate. Which of the following is a potential side effect of oral bisphosphonates?
How long should the patient continue to take alendronate?